Prostate Cancer Non-Metastatic
Also known as: Nonmetastatic Prostate Cancer / Non-Metastatic Prostate Cancer / Biochemically recurrent prostate cancer (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06643 | Denosumab | A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06643 | Denosumab | Tumor necrosis factor ligand superfamily member 11 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12001 | Abemaciclib | 1 / 2 | Active Not Recruiting | 1 |
DB12941 | Darolutamide | 1 / 2 | Active Not Recruiting | 1 |
DB06699 | Degarelix | 1 / 2 | Active Not Recruiting | 1 |
DB00317 | Gefitinib | 1 / 2 | Completed | 1 |
DB00644 | Gonadorelin | 1 / 2 | Active Not Recruiting | 1 |
DB00014 | Goserelin | 1 / 2 | Active Not Recruiting | 1 |
DB00007 | Leuprolide | 1 / 2 | Active Not Recruiting | 1 |
DB12403 | Samarium | 2 | Recruiting | 1 |
DB01128 | Bicalutamide | 3 | Completed | 3 |
DB12941 | Darolutamide | 3 | Completed | 1 |
DB11901 | Apalutamide | Not Available | Completed | 1 |
DB12941 | Darolutamide | Not Available | Completed | 1 |
DB08899 | Enzalutamide | Not Available | Completed | 1 |